Identification of serum protein biomarkers in biliary atresia by mass spectrometry and enzyme-linked immunosorbent assay

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 4, 2012, Pages 370-375

  Song, Zai ^a   Dong, Rui ^a   Fan, Yuxia ^b   Zheng, Shan ^a  

^a CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Biliary atresia; Biomarker; ELISA; SELDI TOF MS

Indexed keywords

APOLIPOPROTEIN C2; APOLIPOPROTEIN C3; BIOLOGICAL MARKER; PLASMA PROTEIN;

ARTICLE; BILE DUCT ATRESIA; BIOINFORMATICS; BIOSTATISTICS; BLOOD ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; INFANT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SUPPORT VECTOR MACHINE; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; UPREGULATION;

APOLIPOPROTEIN C-II; APOLIPOPROTEIN C-III; BILIARY ATRESIA; BIOLOGICAL MARKERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; MALE; MASS SPECTROMETRY; MODELS, BIOLOGICAL; SENSITIVITY AND SPECIFICITY;

EID: 84866937498     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31825bb01a     Document Type: Article

References (30)

1. Hartley J, Harnden A, Kelly D. Biliary atresia. BMJ 2010;340:c2383.
2. Santos JL, Carvalho E, Bezerra JA. Advances in biliary atresia: from patient care to research. Braz J Med Biol Res 2010;43:522-7.
3. Chitsaz E, Schreiber RA, Collet JP, et al. Biliary atresia: the timing needs a changin'. Can J Public Health 2009;100:475-7.
4. Wadhwani SI, Turmelle YP, Nagy R, et al. Prolonged neonatal jaundice and the diagnosis of biliary atresia: a single-center analysis of trends in age at diagnosis and outcomes. Pediatrics 2008;121:e1438-40.
5. Khalil BA, Perera MT, Mirza DF. Clinical practice: management of biliary atresia. Eur J Pediatr 2010;169:395-402.
6. Hay SA, Soliman HE, Sherif HM, et al. Neonatal jaundice: the role of laparoscopy. J Pediatr Surg 2000;35:1706-9.
7. Tang ST, Li SW, Ying Y, et al. The evaluation of laparoscopy-assisted cholangiography in the diagnosis of prolonged jaundice in infants. J Laparoendosc Adv Surg Tech A 2009;19:827-30.
8. Luo J, Qian JH, Yu JK, et al. Discovery of altered protein profiles in epithelial ovarian carcinogenesis by SELDI mass spectrometry. Eur J Gynaecol Oncol 2008;29:233-8. (Pubitemid 351744483)
9. Tomosugi N. Discovery of disease biomarkers by ProteinChip system; clinical proteomics as noninvasive diagnostic tool. Rinsho Byori 2004; 52:973-9.
10. Chen L, Ho DW, Lee NP, et al. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker. Ann Surg Oncol 2010;17: 2518-25.
11. Fan Y, Shi L, Liu Q, et al. Discovery and identification of potential biomarkers of papillary thyroid carcinoma. Mol Cancer 2009;8:79.
12. Liu D, Cao L, Yu J, et al. Diagnosis of pancreatic adenocarcinoma using protein chip technology. Pancreatology 2009;9:127-35.
13. Wang JX, Qin P, Liu QL, et al. Detection and significance of serum protein marker of Hirschsprung disease. Pediatrics 2007;120:e56-60. (Pubitemid 47036217)
14. Zhang Q, Wang J, Dong R, et al. Identification of novel serum biomarkers in child nephroblastoma using proteomics technology. Mol Biol Rep 2011;38:631-8.
15. Sandoval JA, Dobrolecki LE, Huang J, et al. Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer? J Pediatr Surg 2006;41:639-46.
16. Li Y, Altarescu G, Renbaum P, et al. Non-invasive prenatal diagnosis using cell-free fetal DNA in maternal plasma from PGD pregnancies. Reprod Biomed Online 2009;19:714-20.
17. Wang H, Malone JP, Gilmore PE, et al. Serum markers may distinguish biliary atresia from other forms of neonatal cholestasis. J Pediatr Gastroenterol Nutr 2010;50:411-6.
18. Lee CW, Lin MY, Lee WC, et al. Characterization of plasma proteome in biliary atresia. Clin Chim Acta 2007;375:104-9. (Pubitemid 44584228)
19. Monteoliva L, Albar JP. Differential proteomics: an overview of gel and non-gel based approaches. Brief Funct Genomic Proteomic 2004;3: 220-39.
20. Minter RM, Bi X, Ben-Josef G, et al. LPS-binding protein mediates LPS-induced liver injury and mortality in the setting of biliary obstruction. Am J Physiol Gastrointest Liver Physiol 2009;296: G45-54.
21. Alpini G, Lenzi R, Zhai WR, et al. Bile secretory function of intrahepatic biliary epithelium in the rat. Am J Physiol 1989;257:G124-33.
22. Whitington PF, Malladi P, Melin-Aldana H, et al. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia. Pediatr Res 2005;57:837-44. (Pubitemid 40727115)
23. Onori P, Franchitto A, Alvaro D, et al. Immunohistochemical features of bile duct epithelial cells in normal and experimental liver conditions. Ital J Anat Embryol 2001;106:371-8.
24. Maurya P, Meleady P, Dowling P, et al. Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 2007;27:1247-55. (Pubitemid 46807270)
25. Koga S, Miyata Y, Ibayashi H. Plasma lipoproteins and apoproteins in primary biliary cirrhosis. Hepatology 1985;5:286-92. (Pubitemid 15116010)
26. Andersson Y, Majd Z, Lefebvre AM, et al. Developmental and pharmacological regulation of apolipoprotein C-II gene expression. Comparison with apo C-I and apo C-III gene regulation. Arterioscler Thromb Vasc Biol 1999;19:115-21. (Pubitemid 29031919)
27. Tazawa Y, Yamada M, Nakagawa M, et al. Significance of serum lipoprotein-X and gammaglutamyltranspeptidase in the diagnosis of biliary atresia. A preliminary study in 27 cholestatic young infants. Eur J Pediatr 1986;145:54-7. (Pubitemid 16097667)
28. Miller JP. Dyslipoproteinaemia of liver disease. Baillieres Clin Endocrinol Metab 1990;4:807-32.
29. Felker TE, Hamilton RL, Havel RJ. Secretion of lipoprotein-X by perfused livers of rats with cholestasis. Proc Natl Acad Sci U S A 1978;75:3459-63. (Pubitemid 8395092)
30. Albers JJ, Lin J, Roberts GP. Effect of human plasma apolipoproteins on the activity of purified lecithin: cholesterol acyltransferase. Artery 1979;5:61-75. (Pubitemid 10174216)